A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4027-4032

  Speert, David P ^a,b   Steen, Barbara ^a   Halsey, Keith ^a   Kwan, Eddie ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CELL KILLING; CONTROLLED STUDY; HELPER CELL; IMMUNE RESPONSE; INFECTION RISK; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENICITY; PERSISTENT INFECTION; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0032811337     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4027-4032.1999     Document Type: Article

References (30)

1. Burkholder, W. H. 1952. Sour skin, a bacterial rot of onion bulbs. Phytopathology 40:115-117.
2. Burns, J. L., M. Jonas, E. Y. Chi, D. A. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059.
3. Cellier, M., G. Govoni, S. Vidal, T. Kwan, N. Groulx, J. Liu, F. Sanchez, E. Skamene, E. Schurr, and P. Gros. 1994. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J. Exp. Med. 180:1741-1752.
4. Cox, A. D., and S. G. Wilkinson. 1991. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol. Microbiol. 5:641-646.
5. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1745.
6. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
7. Hensel, M., J. E. Shea, C. Gleeson, M. D. Jones, and D. W. Holden. 1995. Simultaneous identification of bacterial virulence genes by negative selection. Science 269:400-403.
8. Hirakata, Y., K. Izumikawa, T. Yamaguchi, S. Igimi, N. Furuya, S. Maesaki, K. Tomono, Y. Yamada, S. Kohno, K. Yamaguchi, and S. Kamihira. 1998. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect. Immun. 66:1748-1751.
9. Hughes, J. E., J. Stewart, G. R. Barclay, and J. R. W. Govan. 1997. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect. Immun. 65:4281-4287.
10. The International Chronic Granulomatous Disease Cooperative Study Group. 1991. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med. 324:509-516.
11. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
12. Kaufmann, S. H. E. 1995. Immunity to intracellular microbial pathogens. Immunol. Today 16:338-342.
13. Krivan, H. C., V. Ginsburg, and D. D. Roberts. 1988. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (Asialo GM1) and gangliotriaosylceramide (Asialo GM2). Arch. Biochem. Biophys. 260:493-496.
14. 13a. Mahenthiralingam, E., et al. Unpublished observations.
15. Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816.
16. McKevitt, A. I., S. Bajaksouzian, J. D. Klinger, and D. E. Woods. 1989. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect. Immun. 57:771-778.
17. Morissette, C., E. Skamene, and F. Gervais. 1995. Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect. Immun. 63:1718-1724.
18. Murray, H. W. 1988. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med. 108:595-608.
19. Nelson, J. W., S. L. Butler, D. Krieg, and J. R. W. Govan. 1994. Virulence factors of Burkholderia cepacia. FEMS Immunol. Med. Microbiol. 8:89-98.
20. Sajjan, S. U., and J. F. Forstner. 1992. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect. Immun. 60:1434-1440.
21. Schurr, E., E. Skamene, A. Forget, and P. Gros. 1989. Linkage analysis of the Bcg gene on mouse chromosome 1: identification of a tightly linked marker. J. Immunol. 142:4507-4513.
22. Skamene, E., P. Gros, A. Forget, P. A. L. Kongshavn, C. St. Charles, and B. A. Taylor. 1982. Genetic regulation of resistance to intracellular pathogens. Nature 297:506-509.
23. Snell, G. I., A. de Hoyos, M. Krajden, T. Winton, and J. R. Maurer. 1993. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 103:466-471.
24. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of non-oxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
25. Steen, B. A., R. E. W. Hancock, and D. P. Speert. 1998. Characterization of a Burkholderia cepacia mutant with increased susceptibility to cationic peptides. Pediatr. Pulmonol. 17(Suppl.):380A.
26. Stieritz, D. D., and I. A Holder. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131:688-691.
27. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-666.
28. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. W. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
29. Yahr, T. L., J. Goranson, and D. W. Frank. 1996. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 22:991-1003.
30. Young, H. A., and K. J. Hardy. 1995. Role of interferon-γ in immune cell regulation. J. Leukoc. Biol. 58:373-381.